Ronit Marcus

Tel Aviv, TA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Anti-CD19 CAR T-cell therapy as salvage treatment for refractory cutaneous polyarteritis nodosa.

Anti-CD19 CAR T-cell therapy as salvage treatment for refractory cutaneous polyarteritis nodosa.

Journal: Annals of the rheumatic diseases

Published: May 23, 2026

Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study.

Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study.

Journal: British journal of haematology

Published: March 31, 2026

Impact of ASTCT Toxicity Grading System on Outcomes After CAR-T for Mature B-Cell Malignancies.

Impact of ASTCT Toxicity Grading System on Outcomes After CAR-T for Mature B-Cell Malignancies.

Journal: Transplantation and cellular therapy

Published: March 04, 2026

Impact of ASTCT toxicity grading system on outcomes after CAR-T for mature B-cell malignancies.

Impact of ASTCT toxicity grading system on outcomes after CAR-T for mature B-cell malignancies.

Journal: Transplantation and cellular therapy

Published: March 04, 2026

Outcomes of Salvage Therapy after Early-Line CD19 Chimeric Antigen Receptor T-Cell Failure in Large B-Cell Lymphoma.

Outcomes of Salvage Therapy after Early-Line CD19 Chimeric Antigen Receptor T-Cell Failure in Large B-Cell Lymphoma.

Journal: Transplantation and cellular therapy

Published: February 02, 2026

Outcomes of Salvage Therapy after Early-Line CD19 Chimeric Antigen Receptor T-Cell Failure in Large B-Cell Lymphoma.

Outcomes of Salvage Therapy after Early-Line CD19 Chimeric Antigen Receptor T-Cell Failure in Large B-Cell Lymphoma.

Journal: Transplantation and cellular therapy

Published: February 02, 2026

Anti-CD19 CAR-T cell therapy as rescue treatment in systemic sclerosis relapsing after autologous haematopoietic stem cell transplantation: a case series.

Anti-CD19 CAR-T cell therapy as rescue treatment in systemic sclerosis relapsing after autologous haematopoietic stem cell transplantation: a case series.

Journal: Rheumatology (Oxford, England)

Published: November 24, 2025

CAR-T as a salvage treatment in polyrefractory RA.

CAR-T as a salvage treatment in polyrefractory RA.

Journal: Rheumatology (Oxford, England)

Published: November 04, 2025

Time of Day of CAR T-Cell Infusion and Outcomes in Large B-Cell Lymphoma.

Time of Day of CAR T-Cell Infusion and Outcomes in Large B-Cell Lymphoma.

Journal: Blood

Published: September 03, 2025

Landmark-Based Evaluations of Long-Term Outcomes After CD19 CAR T-cell Therapy in Large B-Cell Lymphoma.

Landmark-Based Evaluations of Long-Term Outcomes After CD19 CAR T-cell Therapy in Large B-Cell Lymphoma.

Journal: Transplantation and cellular therapy

Published: September 03, 2025

Landmark-Based Evaluations of Long-Term Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.

Landmark-Based Evaluations of Long-Term Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.

Journal: Transplantation and cellular therapy

Published: September 03, 2025

Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma.

Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma.

Journal: Blood

Published: September 03, 2025

Showing 1-12 of 25

Last Updated: 09/26/2026